Beyond the mechanics, T1DM [57] and T2DM [58, 59] impair osteocyte function, causing an increase in expression of sclerostin, an endogenous inhibitor of bone formation, and may be directly related to hyperglycaemia reducing bone cell activity and, subsequently, levels of circulating bone turnover markers [60]. The gene discussed is SOST; the disease is Hyperglycemia.